Trophic Ulcer
3
0
0
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
4 treatments under study, led by Dermal Fibroblasts
Research Leaders
5 sponsors active, led by Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Related Conditions
Often studied with 4 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (3)
Potential Injection of Human Umbilical Cord Secretome in the Case of Trophic Ulcers (Pre-post Intervention)
Treatment of Patients With Non-healing Wounds and Trophic Ulcers Using Autologous Dermal Fibroblasts
Treatment of Patients With Trophic Ulcers Using Mesenchymal Stem Cells
Research Network
Common Treatments
- Dermal Fibroblasts1
- Led Phototherapy1
- Secretome1
- Autologous Adiposederived Mesenchymal Stem Cells1
Active Sponsors
- Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus2
- Belarusian State Medical University1
- Yohanes Firmansyah, dr, MH, MM1
- Tarumanagara University1
- Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology1
Top Investigators
Lead Researcher of Institute of Biophysics and Cell Engineering
Head of the Lab of Institute of Biophysics and Cell Engineering
Ass prof of 2nd Department of Surgical Diseases of BSMU
Head of the Lab of Institute of Biophysics and Cell Engineering
Head of 2 Department of Surgical Diseases of BSMU
Related Conditions
- Nonhealing Wound1
- Leprosy1
- Morbus Hansen1
- Nonhealing Ulcer Of Skin1